193 related articles for article (PubMed ID: 234494)
1. Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement.
Rent R; Ertel N; Eisenstein R; Gewurz H
J Immunol; 1975 Jan; 114(1 Pt 1):120-4. PubMed ID: 234494
[TBL] [Abstract][Full Text] [Related]
2. Complement activation by interaction of polyanions and polycations.
Fiedel BA; Rent R; Myhrman R; Gewurz H
Immunology; 1976 Feb; 30(2):161-9. PubMed ID: 1262050
[TBL] [Abstract][Full Text] [Related]
3. Complement activation by interaction of polyanions and polycations. III. Complement activation by interaction of multiple polyanious and polycations is the presence of C-reactive protein.
Claus DR; Siegel J; Petras K; Skor D; Osmand AP; Gewurz H
J Immunol; 1977 Jan; 118(1):83-7. PubMed ID: 830761
[TBL] [Abstract][Full Text] [Related]
4. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
[TBL] [Abstract][Full Text] [Related]
5. Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.
Siegel J; Rent R; Gewurz H
J Exp Med; 1974 Sep; 140(3):631-47. PubMed ID: 4472155
[TBL] [Abstract][Full Text] [Related]
6. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
Schreiber AD; Frank MM
J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
[TBL] [Abstract][Full Text] [Related]
7. EAC4 and EAC14 production without purified Ci.
Linscott WD
J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
[TBL] [Abstract][Full Text] [Related]
8. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
9. Canine hemolytic complement: optimal conditions for its titration.
Barta O; Barta V
Am J Vet Res; 1973 May; 34(5):653-7. PubMed ID: 4634064
[No Abstract] [Full Text] [Related]
10. Humoral immunostimulation. IV. Role of complement.
Shearer WT; Atkinson JP; Frank MM; Parker CW
J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
[TBL] [Abstract][Full Text] [Related]
11. The modifications of the final stages of the complement reaction by alkali metal cations.
Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
[TBL] [Abstract][Full Text] [Related]
12. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
Loos M; Thesen R
J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
[TBL] [Abstract][Full Text] [Related]
13. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.
Knutzen Steuer KL; Sloan LB; Oglesby TJ; Farries TC; Nickells MW; Densen P; Harley JB; Atkinson JP
J Immunol; 1989 Oct; 143(7):2256-61. PubMed ID: 2506280
[TBL] [Abstract][Full Text] [Related]
14. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
May JE; Frank MM
J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
[No Abstract] [Full Text] [Related]
15. The first component of human complement (C1): kinetics of reaction with its natural substrates.
Strunk R; Colten HR
J Immunol; 1974 Mar; 112(3):905-10. PubMed ID: 4811969
[No Abstract] [Full Text] [Related]
16. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
Berman S; Gewurz H; Mold C
J Immunol; 1986 Feb; 136(4):1354-9. PubMed ID: 3944459
[TBL] [Abstract][Full Text] [Related]
17. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
Galebskaia LV; Solovtsova IL; Riumina EV
Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
[TBL] [Abstract][Full Text] [Related]
18. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.
Baker PJ; Lint TF; McLeod BC; Behrends CL; Gewurz H
J Immunol; 1975 Feb; 114(2 Pt 1):554-8. PubMed ID: 1168218
[TBL] [Abstract][Full Text] [Related]
19. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
[TBL] [Abstract][Full Text] [Related]
20. Complement: effects of C1 binding affinity on the efficiency of the C2 reaction.
Linscott WD
J Immunol; 1972 Dec; 109(6):1327-36. PubMed ID: 4673616
[No Abstract] [Full Text] [Related]
[Next] [New Search]
